2014 - Transplant Infectious Disease Conference

This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.

Multidrug resistant bacteria in solid organ transplant recipients

3.1 - Antimicrobial Stewardship in Transplant Patients

Presenter: Lilian, Abbo, Miami, United States
Authors: Lilian Abbo


  • Review trends in antimicrobial resistance and C. difficile infections
  • Appraise key challenges to implementing ASPs in transplant patients
  • Discuss strategies for implementing antimicrobial stewardship programs in transplant centers
  • Analyze the value of early and appropriate diagnostic testing in guiding antimicrobial therapy and minimizing nonessential antimicrobial exposure.

With the current global crisis in antimicrobial resistance and the threat of a return to the preantibiotic era, it is increasingly urgent that physicians recognize the need for, and the value of antimicrobial stewardship programs (ASPs) and support their existence. ASPs can help avoid inappropriate antimicrobial use and help preserve the efficacy of these important resources.

Patients undergoing organ transplantation are frequently exposed to prolonged courses of prophylactic and therapeutic antimicrobial agents, which may contribute to the occurrence of adverse drug events (such as Clostridium difficile infection), the emergence of multidrug-resistant organisms and increased morbidity and mortality. Early initiation of effective antimicrobial therapy is associated with improved patient outcomes, and rapid pathogen identification and notification to the treating clinician is a key component. Thus, efforts to optimize the selection, dosing and duration of antimicrobial therapy both to improve patient outcomes and to minimize selective pressure on antimicrobial resistance are extremely relevant to immunocompromised patients.

This presentation will outline current trends in antimicrobial resistance, examine the challenges and opportunities to improve antimicrobial use and analyze the value of antimicrobial stewardship programs in transplant patients.

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6